Phase 3 Liver Cancer Trial, Recruiting NCT07285850 Sponsor: Eastern Hepatobiliary Surgery Hospital Condition: Liver Cancer
Back to Liver Cancer

Phase 3 Liver Cancer Trial, Recruiting

NCT07285850
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older (any gender)
  • You are generally able to carry out light activity and care for yourself, but may not be able to do heavy physical work (confirm with trial site)
  • Scans have shown you have advanced liver cancer that is not suitable for surgery
  • An ultrasound, MRI, or special scan has shown you have moderate to severe fatty liver disease
  • You are willing to use contraception during the trial
  • Your doctors expect you to live for at least 3 more months
  • You have at least one area of cancer that can be measured on scans and has not been previously treated with radiation
  • Your blood, liver, kidney, and heart are functioning at levels that meet specific requirements, checked within 7 days before starting treatment (confirm details with trial site)
  • If you are a woman who could become pregnant, you have a negative pregnancy test within 7 days before starting treatment
  • You are willing to use effective contraception during treatment and for 12 months after it ends
  • You are willing to give your consent to take part and are able to follow the trial requirements

Who may not be able to join:

  • You drink heavily — more than roughly 21 standard drinks per week if male, or 14 if female (confirm with trial site)
  • Your tumor has already been treated with targeted therapy, immunotherapy, a procedure called TACE, or radiotherapy
  • You are pregnant, breastfeeding, or have a positive pregnancy test at the start of the trial
  • Scans show that your cancer has spread to your brain or nervous system
  • You have taken part in another clinical drug trial within the past 4 weeks
  • You have had major surgery in the past 4 weeks, or have not fully recovered from surgery
  • You have had radiotherapy in the past 2 weeks
  • You have a history of, or currently have, a condition where your immune system does not work properly or attacks your own body
  • You have previously had an organ transplant or a bone marrow/stem cell transplant
  • You are currently taking medicines that suppress your immune system or high-dose steroids
  • You have HIV, syphilis, or active hepatitis B or C infection
  • You have a known allergy to any of the medicines used in this trial
  • You have a build-up of fluid around your lungs, heart, or abdomen that needs medical treatment
  • You have had serious heart problems in the past 12 months, such as heart failure, heart attack, or significant irregular heartbeat
  • You have had a blood clot, stroke, mini-stroke, or certain heart procedures in the past 6 months
  • You have had stomach or bowel problems (such as surgery, bleeding, or blockages) that could affect how you absorb medication
  • You have a severe uncontrolled infection or a significant kidney problem
  • You have an active lung condition such as interstitial lung disease, COPD, asthma, or a history of tuberculosis
  • You have problems with blood clotting, a tendency to bleed, or are taking blood-thinning medicines (other than low-dose preventive treatment)
  • You have had significant bleeding in the past 3 months (such as coughing up blood, stomach bleeding, or bleeding from varicose veins)
  • You have a known condition that causes bleeding or clotting problems, such as haemophilia
  • You have a history of drug or alcohol misuse, or a mental health condition that might affect your ability to follow the trial
  • You are taking warfarin or similar blood-thinning medicines and have been within 14 days before starting
  • You have any other serious health condition that the trial team believes makes participation unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 18952681068

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Eastern Hepatobiliary Surgery Hospital
Registry
ClinicalTrials.gov
Start date
20 October 2025
Est. completion
30 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

objective response rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov